Clinical Trial Update: Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing the bioavailability and practicality of Envarsus versus Advagraf for preventing liver transplant rejection in liver tran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• Envarsus (tacrolimus)

Snippet

Sponsor: Edward Geissler | Conditions: Prophylaxis Against Liver Transplant Rejection | Phase 4 | Status: ACTIVE_NOT_RECRUITING